Peringkat dalam Saham
#31798
AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on... AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on the surveillance of various cancerous conditions, such as hematological malignancies, breast cancer, and other solid tumors. The company develops, produces, and markets its flagship product, AroCell TK 210 ELISA, an immunoassay kit designed for measuring Thymidine Kinase 1 levels in human blood. Additionally, AroCell provides TUBEX TF, a rapid bacteriological test for the detection of typhoid fever. Founded in 2000, the firm was originally known as Xi Bao Research AB, adopting its current name, AroCell AB (publ), in 2006. It maintains its headquarters in Uppsala, Sweden.
Harga Saham
$0.05234265
Terakhir disinkronkan: 2025-06-23
Kapitalisasi Pasar
$12.06M
Perubahan (1 hari)
-3.01%
Perubahan (1 tahun)
0.00%
Perdagangan AroCell AB (publ) (AROC)
Harga AROC dengan kapitalisasi pasar B
Kapitalisasi pasar dari AroCell AB (publ)(AROC)
Kapitalisasi Pasar: $12.06M
Per August 2026, AroCell AB (publ) memiliki kapitalisasi pasar sebesar $12.06M. Ini menjadikan AroCell AB (publ) sebagai perusahaan 31798th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar AroCell AB (publ) dari 2011 hingga 2026
AROC dibandingkan dengan 5 teratas stocks paling populer
| Harga AROC |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.460T
|
+45,283,296.54%
|
|
|
|
|
$4.489T
|
+37,233,211.71%
|
|
|
|
|
$4.141T
|
+34,342,174.50%
|
|
|
|
|
$3.569T
|
+29,595,356.28%
|
|
|
|
|
$2.798T
|
+23,205,215.77%
|
